Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts

Journal of Cellular Physiology

Volumn 229, Issue 9, 2014, Pages 1170-1176

  Adisetiyo, Helty ^a   Liang, Mengmeng ^a   Liao, Chun Peng ^b   Jeong, Joseph H ^c   Cohen, Michael B ^d   Roy Burman, Pradip ^a   Frenkel, Baruch ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; ANDROGEN; CD31 ANTIGEN; CD45 ANTIGEN; STEM CELL ANTIGEN 1;

ANDROGEN DEPENDENT PROSTATE CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER MODEL; CANCER STEM CELL; CARCINOGENESIS; CASTRATION RESISTANT PROSTATE CANCER; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CAPSULE; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR RECURRENCE; TUMOR SPHEROID;

ANIMALS; CASTRATION; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROBLASTS; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; NEOPLASTIC STEM CELLS; PARACRINE COMMUNICATION; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TUMOR BURDEN; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84901236311     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24546     Document Type: Article

References (26)

1. Adisetiyo H, Liang M, Liao CP, Aycock-Williams A, Cohen MB, Xu S, Neamati N, Conway EM, Cheng CY, Nikitin AY, Roy-Burman P. 2013. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. PLoS ONE 8:e69484.
2. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B, Oh EY, Gaber MW, Finklestein D, Allen M, Frank A, Bayazitov IT, Zakharenko SS, Gajjar A, Davidoff A, Gilbertson RJ. 2007. A perivascular niche for brain tumor stem cells. Cancer Cell 11:69-82.
3. Clark AK, Taubenberger AV, Taylor RA, Niranjan B, Chea ZY, Zotenko E, Sieh S, Pedersen JS, Norden S, Frydenberg M, Grummet JP, Pook DW, Australian Prostate Cancer BioResource, Stirzaker C, Clark SJ, Lawrence MG, Ellem SJ, Hutmacher DW, Risbridger GP. 2013. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer. Biomaterials 34:4777-4785.
4. Collins AT, Maitland NJ. 2006. Prostate cancer stem cells. Eur J Cancer 42:1213-1218.
5. Dayyani F, Gallick GE, Logothetis CJ, Corn PG. 2011. Novel therapies for metastatic castrate-resistant prostate cancer. J Natl Cancer Inst 103:1665-1675.
6. Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S. 2012. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109:22-29.
7. Lang SH, Stark M, Collins A, Paul AB, Stower MJ, Maitland NJ. 2001. Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture. Cell Growth Differ 12:631-640.
8. Liao CP, Adisetiyo H, Liang M, Roy-Burman P. 2010. Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Res 70:7294-7303.
9. Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. 2007. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res 67:7525-7533.
10. Miki J, Rhim JS. 2008. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer Prostatic Dis 11:32-39.
11. Nikitin AY, Matoso A, Roy-Burman P. 2007. Prostate stem cells and cancer. Histol Histopathol 22:1043-1049.
12. Oldridge EE, Pellacani D, Collins AT, Maitland NJ. 2012. Prostate cancer stem cells: Are they androgen-responsive? Mol Cell Endocrinol 360:14-24.
13. Pienta KJ, Bradley D. 2006. Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res 12:1665-1671.
14. Roy-Burman P, Tindall DJ, Robins DM, Greenberg NM, Hendrix MJ, Mohla S, Getzenberg RH, Isaacs JT, Pienta KJ. 2005. Androgens and prostate cancer: Are the descriptors valid? Cancer Biol Ther 4:4-5.
15. Ryan CJ, Tindall DJ. 2011. Androgen receptor rediscovered: The new biology and targeting the androgen receptor therapeutically. J Clin Oncol 29:3651-3658.
16. Sharifi N, Kawasaki BT, Hurt EM, Farrar WL. 2006. Stem cells in prostate cancer: Resolving the castrate-resistant conundrum and implications for hormonal therapy. Cancer Biol Ther 5:901-906.
17. Sluka P, Davis ID. 2013. Cell mates: Paracrine and stromal targets for prostate cancer therapy. Nat Rev Urol 10:441-451.
18. Taylor RA, Toivanen R, Risbridger GP. 2010. Stem cells in prostate cancer: Treating the root of the problem. Endocr Relat Cancer 17:R273-R285.
19. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H. 2003. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4:209-221.
20. Xin L, Lawson DA, Witte ON. 2005. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102:6942-6947.
21. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON. 2007. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25:2760-2769.
22. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR. 2005. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65:8887-8895.
23. Yang S, Pham LK, Liao CP, Frenkel B, Reddi AH, Roy-Burman P. 2008. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Res 68:198-205.
24. Yang ZJ, Wechsler-Reya RJ. 2007. Hit 'em where they live: Targeting the cancer stem cell niche. Cancer Cell 11:3-5.
25. Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, Roy-Burman P, Nikitin AY. 2006. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 66:7889-7898.
26. Zhou Z, Flesken-Nikitin A, Nikitin AY. 2007. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res 67:5683-5690.